Dividends Calendar Earnings Calendar
ADGI

ADGI | Adagio Therapeutics Inc

Adagio Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Waltham, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 428.32M
  • Prev closed:
  • Open: 6.33
  • High: 16.41
  • Low: 6.25
  • 52 week low: 5.57
  • 52 week high: 78.82
  • Dividends:No Dividends

Next ER: June 1, 2022 



Top Stories (ADGI)

    Company Profile

    Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's portfolio of antibodies has been optimized using Adimab's industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio's portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    September 19, 2022
    June 1, 2022
    March 30, 2022-0.77 / -1.02- / -
    March 2, 2022-0.95 / -1.02- / -
    November 15, 2021-0.98 / -0.735- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Apr 22, 2022 2.95 2.96
    3.03
    2.90
    1.17M -1.01%
    Apr 21, 2022 2.98 3.20
    3.21
    2.94
    1.60M -6.29%
    Apr 20, 2022 3.18 3.24
    3.26
    3.14
    1.63M -2.15%
    Apr 19, 2022 3.25 3.17
    3.35
    3.04
    1.36M 3.50%
    Apr 18, 2022 3.14 3.50
    3.56
    3.13
    2.08M -12.53%
    Apr 14, 2022 3.59 3.65
    3.76
    3.57
    2.01M -7.24%
    Apr 13, 2022 3.87 3.67
    3.94
    3.65
    1.58M 5.74%
    Apr 12, 2022 3.66 3.69
    3.76
    3.61
    809.38K -0.81%
    Apr 11, 2022 3.69 3.83
    3.83
    3.62
    1.18M -4.4%
    Apr 8, 2022 3.86 4.00
    4.02
    3.84
    1.39M -3.74%
    view more
    NASDAQ - Nasdaq Stock Market

    News

    News for (ADGI)

    This company doesn't provide a dividend.


    Talk about Adagio Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Jun 1, 2022 (Same day)

    adgi 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 25
    HOLD 75
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Currency Trading For Dummies
    Buy on Amazon

    Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?